Laura Piccardi | Cognitive Neuroscience | Women Researcher Award

Prof. Dr. Laura Piccardi | Cognitive Neuroscience | Women Researcher Award

Sapienza University of Rome | Italy

Laura Piccardi is a distinguished scholar and full professor in the Department of Psychology at Sapienza University of Rome, Italy. Renowned for her expertise in spatial cognition, neuropsychology, and individual differences, she has made significant contributions to understanding how humans navigate and process spatial information across the lifespan. Her academic journey has been marked by prestigious positions, extensive research output, and influential collaborations with leading institutions worldwide, including Harvard Medical School, Karolinska Institutet, and the National University of Singapore. With over two hundred peer-reviewed publications, she is recognized for integrating experimental and clinical approaches to explore cognitive decline, hemineglect, and navigational memory. Beyond research, she is a dedicated educator, mentoring undergraduate, graduate, and doctoral students in psychology and cognitive neuroscience. Her work bridges theoretical insight with applied relevance, making her a leading figure in cognitive neuroscience and a sought-after expert in multidisciplinary research on spatial and cognitive processes.

Profile

Google scholar

Education

Laura Piccardi pursued her academic formation at Sapienza University of Rome, where she earned her doctoral degree in cognitive neuroscience. Following her doctoral studies, she engaged in advanced postdoctoral research at the prestigious Collège de France and the Hospital Pitié-Salpêtrière in Paris, working under world-leading experts in spatial navigation and neuropsychology. She began her academic career as a researcher in the Life, Health, and Environmental Science Department at the University of L’Aquila, where she deepened her focus on spatial memory and cognitive differences. Her progression from researcher to associate professor reflected her outstanding contributions to the field, leading to her eventual appointment as full professor at Sapienza University of Rome. Throughout her academic training, she complemented her formal education with international collaborations, advanced methodological training, and interdisciplinary research experiences, shaping her into a versatile scholar with strong expertise at the intersection of cognitive neuroscience, clinical neuropsychology, and spatial cognition research

Experience

Laura Piccardi’s professional experience spans research, teaching, and clinical practice. She has held faculty positions at the University of L’Aquila and Sapienza University of Rome, where she teaches courses in general psychology, cognitive neuropsychology, spatial cognition, and learning disabilities. Her research has been supported by competitive grants, leading projects on spatial cognition, navigational memory, emotional-cognitive variables, and eco-sustainable decision-making. In addition to academic roles, she has collaborated extensively with rehabilitation and medical institutes, such as the IRCCS Fondazione Santa Lucia and San Raffaele facilities, integrating clinical work with cognitive neuroscience research. Internationally, she has engaged in partnerships with institutions in Singapore, Spain, Sweden, France, and the United States, expanding her research impact across cultural and methodological contexts. Her experience reflects a balance between laboratory-based research, applied clinical studies, and educational leadership, establishing her as a versatile academic committed to advancing both scientific knowledge and practical applications in psychology

Awards and Honors

Awards and Honors (150 words)
Laura Piccardi’s work has earned recognition through prestigious awards, editorial appointments, and invitations to speak at international conferences. Early in her career, she received the Young Researcher Award from Sapienza University of Rome, highlighting her potential for impactful contributions to cognitive neuroscience. She serves as an associate editor for prominent journals, including Frontiers in Cognitive Neuroscience, and as a guest editor for thematic issues in learning and memory. Her reputation in the field is further underscored by her role as a symposium organizer, invited speaker, and scientific reviewer for leading academic outlets. Her research collaborations with globally renowned universities and medical centers also reflect her standing in the international scientific community. These honors, combined with sustained funding for innovative projects, demonstrate her influence in shaping current discourse in spatial cognition, neuropsychology, and cognitive aging, while also inspiring a new generation of researchers through mentorship and cross-disciplinary engagement.

Research Focus

Laura Piccardi’s research centers on spatial cognition, exploring how individuals perceive, process, and remember spatial information, and how these abilities vary across populations. She investigates individual differences in spatial abilities, the cognitive mechanisms underlying navigation, and the neural bases of these processes in both healthy and clinical groups. Her work encompasses neuropsychological conditions such as hemineglect, multiple sclerosis, and cognitive decline, aiming to identify cognitive markers that could inform rehabilitation strategies. She has developed innovative experimental paradigms using virtual reality to study spatial memory, navigational skills, and the role of emotional and cognitive factors in decision-making. Additionally, her research addresses how environmental, social, and psychological factors influence spatial abilities, particularly in aging populations. By integrating clinical, experimental, and technological approaches, her work contributes to theoretical models of spatial cognition while offering practical implications for education, clinical rehabilitation, and human-environment interaction design

 

Publications

 

Title: Neural bases of personal and extrapersonal neglect in humans
Year: 2007
Citation: 403

Title: Development of neuropsychiatric symptoms in poststroke patients: a cross‐sectional study
Year: 2004
Citation: 321

Title: Gender effects in young road users on road safety attitudes, behaviors and risk perception
Year: 2016
Citation: 314

Title: Where do bright ideas occur in our brain? Meta-analytic evidence from neuroimaging studies of domain-specific creativity
Year: 2015
Citation: 311

Title: The meditative mind: A comprehensive meta‐analysis of MRI studies
Year: 2015
Citation: 278

Title: Walking in the Corsi test: which type of memory do you need?
Year: 2008
Citation: 195

Title: Frontal EEG asymmetry of mood: a mini-review
Year: 2017
Citation: 165

Title: Cognitive reserve in healthy aging and Alzheimer’s disease: a meta-analysis of fMRI studies
Year: 2016
Citation: 133

Conclusion

Laura Piccardi stands out as a leading figure in spatial cognition and neuropsychology, seamlessly integrating research, teaching, and clinical expertise. Her contributions span fundamental theory, experimental innovation, and applied practice, making her work relevant to both scientific and societal challenges. Through sustained international collaborations, influential publications, and impactful mentorship, she has advanced understanding of spatial memory, cognitive decline, and navigational processes. Her ability to bridge interdisciplinary perspectives ensures her research remains at the forefront of cognitive neuroscience. With a career defined by intellectual rigor, creativity, and collaborative spirit, she continues to shape the future of spatial cognition research worldwide.

Jesus Avila | Tauopathies | Best Researcher Award

Prof. Jesus Avila | Tauopathies | Best Researcher Award

Dr. Jesus Avila is a distinguished cognitive scientist and Professor ad honorem at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), Spain. He obtained his degree in Chemistry and PhD in Molecular Biology from Universidad Complutense Madrid, focusing on RNA polymerase in B. subtilis. His postdoctoral research at NIH, USA, centered on the SV40 virus. Throughout his prolific career, Dr. Avila has made groundbreaking contributions to understanding the neuronal cytoskeleton, particularly tau protein, its role in Alzheimer’s disease, and tauopathies. With over 694 published journal articles, 33 books, 4 patents, and collaborations across the USA, France, UK, Germany, and Spain, his work is internationally recognized. He serves on editorial boards of prestigious journals including EMBO J, FEBS Letters, Neuroscience, and Journal of Alzheimer’s Disease (Deputy Editor). Dr. Avila is a member of EMBO, Academia Europaea, AAAS, and Royal Academies of Sciences and Medicine of Spain.

Professional Profile

Education

Dr. Jesus Avila pursued his higher education at Universidad Complutense Madrid (UCM), earning a degree in Chemistry. He further specialized by completing a PhD in Molecular Biology at UCM, where his research focused on the B. subtilis RNA polymerase system. This solid foundation in molecular biology provided him with the expertise to investigate complex neurobiological mechanisms. He then advanced his academic career with postdoctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, USA, where he studied the SV40 virus—a crucial step that introduced him to advanced molecular virology and neurobiology techniques. This diverse academic background enabled him to establish a globally recognized research portfolio in neurodegeneration, particularly tau protein’s role in neuronal function and dysfunction.

Experience

Dr. Avila has an illustrious career spanning several decades at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), where he has led pioneering research into the neuronal cytoskeleton, tau protein dysfunction, and neurodegenerative diseases. His early research at NIH on SV40 virus provided him with robust molecular expertise, which he translated into comprehensive studies on tauopathies and Alzheimer’s disease upon returning to Spain. Dr. Avila has successfully led over 30 major research projects, consulted on 8 industry collaborations, and published 694 peer-reviewed articles. His work includes the authorship of 33 books and the filing of 4 patents. Through sustained collaborations with global leaders in neuroscience from the USA, France, UK, Germany, and Spain, he has significantly advanced the understanding of aging and cognitive decline. His academic leadership and editorial roles underscore his vast experience in guiding both research and scientific discourse.

Research Interests

Dr. Avila’s research primarily investigates the neuronal cytoskeleton, with a central focus on tau protein and its role in neurodegeneration. Beginning with tau’s structural function in neurons, his work has expanded to explore how tau dysfunction contributes to Alzheimer’s disease and other tauopathies. Utilizing molecular and cellular approaches, including advanced mouse models, he has dissected the pathological mechanisms linking tau pathology to cognitive decline. Recognizing aging as the principal risk factor for Alzheimer’s disease, his current investigations target neuronal rejuvenation strategies to mitigate age-associated neurodegeneration. His integrative approach combines molecular biology, neurogenetics, and translational models, contributing significantly to the understanding of disease progression and potential therapeutic interventions. Through over 694 publications, 33 books, multiple patents, and international collaborations, Dr. Avila has substantially advanced the field of cognitive neuroscience, particularly in understanding and combating tau-mediated cognitive disorders.

Awards

Dr. Avila’s exemplary contributions have earned him numerous prestigious honors. He is an elected member of EMBO (European Molecular Biology Organization), Academia Europaea, AAAS (American Association for the Advancement of Science), and both the Royal Academies of Sciences and Medicine of Spain—testament to his global recognition and scientific excellence. His editorial appointments with highly respected journals such as EMBO J, FEBS Letters, Neuroscience, and his role as Deputy Editor of the Journal of Alzheimer’s Disease further validate his authority in cognitive and neurodegenerative research. His citation index surpasses 100 on Scopus, reflecting the significant influence of his work. His extensive collaborations with leading international research teams highlight his status as a respected leader in the global scientific community. The combination of his research excellence, mentorship, and leadership has positioned him as one of the foremost experts in cognitive science and neurobiology.

Conclusion

Dr. Jesus Avila’s distinguished career combines pioneering research on tau protein and Alzheimer’s disease, extensive international collaborations, over 694 publications, leadership roles in major journals, multiple prestigious memberships, and an unwavering focus on neuronal rejuvenation strategies, positioning him as a world-leading cognitive scientist whose work continues to advance global understanding of neurodegeneration.

 Publications

  • Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer’s disease

    Experimental Neurology
    2025 | Journal article

    EID:

    2-s2.0-85208758184

    Part ofISSN: 10902430 00144886
    CONTRIBUTORS: Merino-Serrais, P.; Soria, J.M.; Arrabal, C.A.; Ortigado-López, A.; Esparza, M.Á.G.; Muñoz, A.; Hernández, F.; Ávila, J.; DeFelipe, J.; León-Espinosa, G.
  • Retrotransposon Protein L1 ORF1p Expression in Aging Central Nervous System

    International Journal of Molecular Sciences
    2025-05-04 | Journal article
    CONTRIBUTORS: Laura Vallés-Saiz; Aaron Abdelkader-Guillén; Jesús Ávila; Félix Hernández
  • Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

    Biochemistry
    2025-04-15 | Journal article
    CONTRIBUTORS: Indalo Domene-Serrano; Raquel Cuadros; Vega García-Escudero; Francisco Vallejo-Bedia; Ismael Santa-María; Laura Vallés-Saiz; Félix Hernandez; Jesús Avila
  • Peptide Family Promotes Brain Cell Rejuvenation and Improved Cognition through Peripheral Delivery

    ACS Omega
    2025-04-08 | Journal article
    CONTRIBUTORS: Alejandro Anton-Fernandez; Indalo Domene-Serrano; Raquel Cuadros; Rocio Peinado-Cahuchola; Margarita Sanchez-Pece; Felix Hernandez; Jesus Avila
  • Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer\’s disease

    Progress In Neurobiology
    2025-04-01 | Journal article | Author

    SOURCE-WORK-ID:

    CSIC-GB950859

    EID:

    2-s2.0-85219079150

    Part ofISSN: 0301-0082
    CONTRIBUTORS: Alejandro Anton-Fernandez; Ruiz de Alegría, Álvaro; Mariscal-Casero, Ana; Roldán-Lázaro, Marta; Peinado-Cauchola, Rocío; Jesus Avila; Felix Hernandez
  • Hippocampal rejuvenation by a single intracerebral injection of one‐carbon metabolites in C57BL6 old wild‐type mice

    Aging Cell
    2025-01 | Journal article
    CONTRIBUTORS: Alejandro Antón‐Fernández; Rocío Peinado Cauchola; Félix Hernández; Jesús Ávila
  • Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3

    eBioMedicine
    2024 | Journal article

    EID:

    2-s2.0-85181837483

    Part ofISSN: 23523964
    CONTRIBUTORS: Ruiz-Gabarre, D.; Vallés-Saiz, L.; Carnero-Espejo, A.; Ferrer, I.; Hernández, F.; Garcia-Escudero, R.; Ávila, J.; García-Escudero, V.
  • Involvement of the cellular prion protein in seeding and spreading of sarkosyl-derived fractions of Alzheimer´s disease in Prnp mutant mice and in the P301S transgenic tauopathy mice model

    bioRxiv
    2024 | Other

    EID:

    2-s2.0-85184321414

    Part of ISSN: 26928205
    CONTRIBUTORS: Sala-Jarque, J.; Gil, V.; Andrés-Benito, P.; Lidón, L.; Yanac-Huertas, R.E.; López-León, C.F.; Hernández, F.; Ávila, J.; Lanciego, J.L.; Soriano, J. et al.

Hong Wang | Memristors | Best Researcher Award

Prof. Dr. Hong Wang | Memristors | Best Researcher Award

Dr. Hong Wang is an accomplished Associate Professor at Hebei University, China, specializing in the field of neuromorphic electronics and low-dimensional ferroelectric materials. With a strong academic foundation in Physics, Integrated Circuits, and Optical Engineering, she has rapidly advanced in her field since earning her doctorate in 2021. Her research has led to 15 SCI-indexed publications as a first author, 8 patents, and over 1300 citations, underscoring her scientific impact. Dr. Wang actively collaborates with leading researchers from institutions such as the National University of Singapore, the Chinese Academy of Sciences, and Jilin University, achieving multiple experimental firsts in ferroelectricity and memristor behavior. Her innovative work bridges material science and cognitive computing, making significant contributions to optoelectronic sensing and neuromorphic systems. She is a member of several prestigious scientific societies, including the Chinese Optical Society. Dr. Wang’s dedication and research excellence make her a standout in cognitive science innovations.

Profile

🎓 Education

Dr. Hong Wang’s academic journey began with a Bachelor’s degree in Physics from Beihua University in 2016, which laid the foundation for her interdisciplinary approach to electronic materials. She then earned her Master’s degree in Integrated Circuits from Hebei University in 2018, further refining her expertise in semiconductor and electronic system design. Driven by a passion for optical and neuromorphic technologies, she pursued a PhD in Optical Engineering at Hebei University, completing it in 2021. Her doctoral research focused on the application of low-dimensional ferroelectric materials, contributing valuable insight into the behavior of memristive systems and their implications for artificial neural networks. This strong educational background has enabled her to explore innovative technologies in cognitive sensing and computing, bridging physics, materials science, and neural engineering. Her academic training not only exemplifies depth and rigor but also reflects a unique ability to translate theoretical research into applied cognitive systems.

🧪 Experience

Since 2021, Dr. Hong Wang has served as an Associate Professor at the School of Electronic Information and Engineering, Hebei University. In this role, she has taken on responsibilities spanning research leadership, mentoring graduate students, and leading interdisciplinary projects at the frontier of neuromorphic computing. She has directed five major research projects and collaborated internationally with scholars from Singapore, the Chinese Academy of Sciences, and Jilin University. Her work has provided novel insights into ferroelectricity in materials like SnSe and ReSe₂, and its application in memristive devices. In addition to her academic duties, Dr. Wang has contributed to two industry consultancy projects, aligning academic innovation with technological advancement. Her ability to bridge material innovation with neural system architecture distinguishes her as a versatile and future-oriented cognitive scientist. Her professional experience is marked by innovation, collaboration, and a commitment to enhancing cognitive systems through novel material applications.

🏅 Awards and Honors

While specific awards are not explicitly listed, Dr. Hong Wang’s impressive research metrics and collaborations signify her recognition within the global scientific community. With 15 SCI-indexed publications as first author and over 1365 citations, her work has garnered significant academic attention. Her successful collaborations with leading institutions like the National University of Singapore and the Chinese Academy of Sciences validate her contributions through groundbreaking experimental confirmations in ferroelectric behavior. Additionally, she holds 8 patents, reflecting the originality and applied potential of her research in neuromorphic computing. Her memberships in the Chinese Optical Society, the Chinese Institute of Electronics, and the Chinese Society for Optical Engineering indicate peer recognition and professional trust. These accomplishments, coupled with her high-impact research output, suggest that Dr. Wang is a strong contender for prestigious awards in cognitive science and materials research, and she is an exemplary nominee for the Best Researcher Award in Cognitive Science.

🔬 Research Focus

Dr. Hong Wang’s research centers on the design and application of neuromorphic memristors using low-dimensional ferroelectric materials. She explores how novel quantum dots and two-dimensional semiconductors, such as SnSe and ReSe₂, can mimic synaptic behavior for brain-like computing. A notable achievement includes her demonstration of robust dual-mode optical sensing using ferroelectric quantum dots, enabling both short-range and remote synapse-like responses, leading to high-accuracy image recognition systems. Her experimental work debunks traditional notions in electronics, such as the inertness of Pd electrodes, and provides novel insights into conductive filament formation. Her research has practical implications in artificial vision systems, optoelectronic sensing, and cognitive learning circuits. She is pioneering the application of ferroelectric polarization for neuromorphic behavior, with implications for smart sensing and adaptive cognitive devices. Through multidisciplinary collaborations and material innovations, Dr. Wang is shaping the future of neuromorphic computing, advancing cognitive technologies toward higher efficiency and closer brain mimicry.

Conclusion

Dr. Hong Wang is an emerging leader in neuromorphic computing, merging ferroelectric material innovation with cognitive system design, making her a strong candidate for the Best Researcher Award.

Publications

Elsa Pittaras | Neuroscience | Women Researcher Award

Dr. Elsa Pittaras | Neuroscience | Women Researcher Award

Elsa Pittaras is a Basic Life Research Scientist at Stanford University, specializing in neuroscience, cognition, and sleep research. With expertise in molecular biology, neuroanatomy, pharmacology, and behavior, she has extensively studied decision-making processes in mice. Her research has contributed significantly to understanding sleep deprivation’s effects on cognition and memory in Down Syndrome and Alzheimer’s disease models. She has published multiple papers as both first and last author, showcasing her leadership in neuroscience. Elsa’s goal is to advance research on mood disorders, cognition, and neurochemistry, aspiring to become an independent researcher in the U.S. 🇺🇸🔬🧠

Profile

Education 🎓

Elsa Pittaras earned a B.S. in Physiology from the University of Caen (2010), an M.S. in Neuroscience from the University of Paris Sud and ENS Cachan (2012), and a Ph.D. in Neuroscience from Neuro-PSI and the Biomedical Research Unit of the French Army (2016). Her multidisciplinary foundation in biology, physics, chemistry, and mathematics from Châtelet, Douai (2009) laid the groundwork for her neuroscience expertise. Throughout her education, she focused on decision-making, sleep deprivation, and neurochemical mechanisms in cognition. 🧠📚🎓

Experience 👨‍🏫

Elsa Pittaras has been a Basic Life Research Scientist at Stanford University since 2022, focusing on cognitive enhancement in Down Syndrome and Alzheimer’s disease models. She was a Postdoctoral Fellow at Stanford (2017-2022), investigating sleep and circadian rhythms’ effects on memory. Previously, she conducted research at the Biomedical Research Unit of the French Army (2016-2017) and completed her Ph.D. at Neuro-PSI. Her career includes internships in neuroscience at Neuro-PSI (2011-2012) and clinical observations at CHU Caen (2010). 🏛️🧬🧪

Research Interests 🔬

Elsa’s research explores decision-making, memory, and sleep in neurodevelopmental disorders. She pioneered the Mouse Gambling Task, revealing individual decision-making strategies. Her Ph.D. identified neurochemical markers of decision-making behaviors and the effects of sleep deprivation. At Stanford, she investigates sleep’s impact on cognition in Down Syndrome and Alzheimer’s models, aiming to improve memory and sleep quality through pharmacological interventions. Her work bridges behavioral neuroscience with neurochemistry to enhance cognitive function. 🧠💡🛌

Awards & Recognitions 🏅

Elsa has received prestigious grants, including the Jerome Lejeune Research Grants (2019, 2020), the Fyssen Foundation Research Grant (2017), and travel awards for conferences such as T21RS (2021) and Advances in Sleep and Circadian Science (2019). She was also recognized by the French Society for Research and Sleep Medicine (2014) and received a European Neuroscience Federation travel award (2016). 🏅

Publications 

  • Selectively Blocking Small Conductance Ca2+-Activated K+ Channels Improves Cognition in Aged Mice.

  • Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

  • Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease.

  • Inter-individual differences in cognitive tasks: focusing on the shaping of decision-making strategies

  • Handling, task complexity, time-of-day, and sleep deprivation as dynamic modulators of recognition memory in mice

  • Enhancing sleep after training improves memory in down syndrome model mice

 

said Pournaghash-tehrani | Neuroscience | Best Faculty Award

Dr. said Pournaghash-tehrani | Neuroscience | Best Faculty Award

 

Profile

  • Googlescholar
  • Researchgate

Education

Said Pournaghash-Tehrani earned his Doctor of Philosophy in Psychology in 1993 from The American University in Washington, D.C., where he also completed his Master of Arts in Psychology in 1990. He holds a Bachelor of Science in Distributive Science from the same institution, which he obtained in 1986. Fluent in English and German, he also has familiarity with French. He can be reached via email at spournaghash@yahoo.com or by telephone at 011-98-09122074388.

Work experience
  • Said Pournaghash-Tehrani has extensive academic and research experience in psychology. He served as a Research Associate in 2001 at the Department of Pharmacology and Experimental Therapeutics, Loyola University’s Stritch School of Medicine in Chicago, Illinois. In 2002, he took a sabbatical as a researcher at the Department of Psychology, Carleton University in Ottawa, Canada, focusing on cross-cultural studies related to Iranian attitudes towards the West. Since 2002, he has been an Assistant Professor in the Department of Psychology at Tehran University, having previously held the same position at Azzahra University in Tehran from 1996 to 2001. Additionally, he was a member of the Scientific Council on Energy and Economic Studies at the Institute for International and Political Studies (IPIS) from 1998 to 2000, where he also worked as a political researcher. His early academic career included serving as a Teaching and Research Assistant at The American University’s Department of Psychology from 1987 to 1990, where he contributed to courses such as Introduction to Psychology, Neuroscience Seminar, Psychopharmacology, Neuropsychology, Biological Basis of Behavior, and Learning and Behavior.

Books

Fundamentals of Clinical Psychopharmacology, (2007); Samt Publications
-Drugs and Behavior, (2004); Samt Publications.
-Physiological Psychology, Tehran University Publication.
-Intimacy; Alzahra University Publication.
-Theories of Addiction, Alzahra University Publication.

Conference Presentations

Said Pournaghash-Tehrani has contributed extensively to neuroscience and psychology research, presenting his findings at prestigious conferences such as the Society for Neuroscience and the Eastern Psychological Association. His work has focused on drug discrimination learning, conditioned taste aversion, and the effects of opioids and their antagonists. In 1987, he co-authored studies assessing the discriminative stimulus properties of naloxone and the failure of cholecystokinin to counteract morphine sulfate’s effects. His later research explored the antagonism of morphine stimuli, the role of buprenorphine in opiate-naive and dependent animals, and the impact of RO15-4513 on ethanol-induced taste aversion. He has collaborated with notable researchers, including A.L. Riley, contributing to investigations on diazepam exposure and behavioral toxicology. His presentations in New Orleans, Washington, D.C., Boston, and other major research venues highlight his significant role in advancing psychopharmacology and behavioral neuroscience.

Publication

Crhistiane Andressa da Silva | Chronobiology and Memory | Neurocognitive Breakthrough Award

Dr. Crhistiane Andressa da Silva | Chronobiology and Memory | Neurocognitive Breakthrough Award

 

Estúdio Amanhecer, Brazil

Profile

Education

She earned her Doctorate in Psychology from the Universidade Federal do Rio Grande do Norte (UFRN), Natal, Brazil, in 2012, with a Sandwich Doctorate at the Universitat de Barcelona under the supervision of Antoni Díez-Noguera. Her doctoral research, titled SAGUIS (Callithrix jacchus) SOB CICLO CLARO-ESCURO DE 21 H: UM MODELO DE DESSINCRONIZAÇÃO FORÇADA EM PRIMATA DIURNO, was conducted under the guidance of John Fontenele Araujo, with Carolina Virgínia Macedo de Azevedo as a co-advisor. She received a scholarship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.

She completed her Master’s in Pharmacology at UFRN in 2007, with a thesis titled EFEITOS DE VOCALIZAÇÕES DE CO-ESPECÍFICOS E DO ESCURO SOBRE O RITMO CIRCADIANO DA ATIVIDADE MOTORA EM SAGÜIS (Callithrix jacchus), under the supervision of Carolina Virgínia Macêdo de Azevedo. Her research was supported by a CAPES scholarship.

She earned her Bachelor’s degree in Biological Sciences from UFRN in 2003, with a thesis titled Perfil Diário do Comportamento de Autocatação Durante Um Ciclo Ovariano em Díades de Saguis (Callithrix jacchus), under the supervision of Carolina Virgínia Macêdo de Azevedo. She received a scholarship from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil.

Work experience

She worked as a Postdoctoral Researcher at the Universidade Federal da Paraíba (UFPB) from 2014 to 2017 under a full-time and exclusive contract. She then continued her postdoctoral research at the Universidade Federal de Pernambuco (UFPE) from 2017 to 2018 under the same work scheme.

In 2018, she served as a part-time Professor at Faculdade Escritor Osman da Costa Lins (FACOL), where she taught the course Práticas Integrativas Complementares em Saúde for the Physiotherapy program.

Since 2021, she has been the owner and full-time instructor at Estúdio Amanhecer, where she teaches yoga.

Areas of Expertise

She specializes in Public Health within the broader field of Health Sciences, as well as Physiology and General Biology within Biological Sciences. Her expertise also extends to Zoology, with a focus on Animal Behavior.

Scientific, Technological & Academic Production

She has contributed to bibliographic research and publications in her fields of study.

Citations

Her research has been cited in various academic databases:

  • Web of Science: 44 citations across 3 articles (as of June 2, 2024), with an H-index of 3.
  • Google Scholar: 26 citations across 9 articles (as of January 17, 2017).

The citation search included variations of her name: Silva, C.A.; da Silva, C.A.; CA da Silva; CA Silva; C da Silva, Crhistiane Andressa da Silva; Christiane Andressa da Silva; da Silva, Christiane Andressa; da Silva, Crhistiane Andressa

Awards & Recognitions

  • 2023 & 2024: TOP MASTER GOLD award by popular vote, recognized as a distinguished professional in her field in Rio Grande do Norte for her contributions to local development.
  • 2022: Named Best Yoga Teacher of 2022 in Natal and awarded Best of the Year in Natal.
  • 2017: Secured second place in the Banner category on the theme Chronobiology at the IX Symposium of Psychobiology.

Publication

Marcelo Luis Berthier | Neuroscience| Best Researcher Award

Prof. Marcelo Luis Berthier | Neuroscience| Best Researcher Award

 

Unversidad de Málaga, Spain

Profile

Education

Marcelo Luis Berthier obtained his degree in Medicine (1972-1976) and completed residency training in Neurosurgery (1977-1980), later specializing in Neurology (1980). He served as a staff neurologist at the Institute of Neurological Research, FLENI, Buenos Aires, Argentina (1980-1989), before becoming a research fellow in the Department of Neurology at Clinic Hospital of Barcelona, Spain (1989-1990). From 1991 to 2000, he was a staff neurologist and physician in charge of the Behavioural Neurology Unit at the Clinic University Hospital of Malaga. He earned a PhD in Neuroscience (cum laude) from the University of Malaga and coordinated the Group of Behavioural Neurology and Dementia of the Spanish Neurological Society (2004-2006). In 2004, he founded and directed the Unit of Cognitive Neurology and Aphasia at the Centro de Investigaciones Médico-Sanitarias, University of Malaga, leading it until 2023. Additionally, he served as the director of the Consolidated Research Group on Cognitive Neuroscience: Aphasia and Related Disorders (UNCA, C-12) at the Instituto de Investigación Biomédica de Málaga (IBIMA – Plataforma BIONAND).

Work experience

Dr. Marcelo L. Berthier Torres has led and contributed to several groundbreaking research projects in cognitive neurology and aphasia. As a co-investigator, he participated in the Telerehabilitation in Aphasia project (2021-2023), which evaluated the effectiveness of telerehabilitation compared to face-to-face therapy and identified predictive biomarkers of response, funded by the Junta de Andalucía. He also served as the principal investigator for a study on the efficacy of combined treatment with donepezil, intensive rehabilitation, and transcranial direct current stimulation in chronic post-stroke aphasia (2016-2019), funded by the Instituto de Salud Carlos III. Additionally, he has contributed to the Proyectos de Generación de Conocimiento “Frontera”, an initiative under the FEDER Andalucía 2014-2020 program, which investigates brain biomarkers for individualized treatment approaches in chronic post-stroke aphasia

Areas of Research

Dr. Marcelo L. Berthier Torres has made significant contributions to the treatment of post-stroke aphasia and speech-language disorders. He conducted the first open-label and randomized, placebo-controlled, double-blind trials investigating the use of cognitive-enhancing drugs (donepezil and memantine) alone and in combination with standard aphasia therapy or intensive language-action therapy (ILAT) in chronic post-stroke aphasia. His pioneering studies stimulated international research on aphasia pharmacotherapy, leading to clinical translation. Today, donepezil and memantine, alone or combined with therapy, are widely used off-label for post-stroke aphasia and language disturbances associated with neurodegenerative disorders like Alzheimer’s disease and primary progressive aphasia.

Publication

  • Revisiting the boundaries of different altered accents profiles

    Cortex
    2025-03 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Ignacio Moreno-Torres; Jo Verhoeven; Guadalupe Dávila
  • Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

    CNS Drugs
    2023-07 | Journal article
    CONTRIBUTORS: Guadalupe Dávila; María José Torres-Prioris; Diana López-Barroso; Marcelo L. Berthier
  • Pharmacotherapy for post-stroke aphasia: what are the options?

    Expert Opinion on Pharmacotherapy
    2023-07-24 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Guadalupe Dávila
  • Brain structural and functional correlates of the heterogenous progression of mixed transcortical aphasia

    Brain Structure and Function
    2023-05-31 | Journal article
    CONTRIBUTORS: Diana López-Barroso; José Paredes-Pacheco; María José Torres-Prioris; Guadalupe Dávila; Marcelo L. Berthier
  • Controlling the past, owning the present, and future: cholinergic modulation decreases semantic perseverations in a person with post-stroke aphasia

    Aphasiology
    2022-11-02 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Daniel Santana-Moreno; Álvaro Beltrán-Corbellini; Juan C. Criado-Álamo; Lisa Edelkraut; Diana López-Barroso; Guadalupe Dávila; María José Torres-Prioris

Wei Jiang | Cognitive and neuropathology | Women Researcher Award

 Dr. Wei Jiang | Cognitive and neuropathology | Women Researcher Award

Medical University of South Carolina , United States

Her academic focus includes microbiome, B cell/autoantibody interactions, and disease pathogenesis, with particular emphasis on HIV, addictive drugs, and systemic lupus erythematosus (SLE). She is involved in several clinical and translational research projects, including R01DA059854 (Jiang & Sheng), investigating the impacts of drug abuse on autoantibodies and immune reconstitution in HIV. She also works on CSRD Merit I01 CX002422, exploring B cell-mediated immunological failure in HIV-infected individuals on antiretroviral therapy. Additionally, she contributes to NIDA-funded studies, such as R01DA055523, examining the oral microbiome’s effect on cognition in HIV-infected cannabis users, and R01DA059538, investigating HIV persistence in cocaine users. Furthermore, she collaborates on a Translational Science Award project exploring the oral microbiome’s impact on cognition in Alzheimer’s disease.

 

 

Profile

Education:

She earned her M.S. in Epidemiology and Biostatistics from Case Western Reserve University, Medical School, Cleveland, USA, in 2012. Prior to that, she completed a Postdoctoral fellowship at Case Western Reserve University, Medical School, Cleveland, USA, in 2008. She holds an M.S. in Immunology from Capital Medical University, Beijing, China, which she completed in 2001. She also received her M.D. in Internal Medicine from Capital Medical University, Beijing, China, in 1997.

BRIEF RESEARCH INTEREST STATEMENT:

She has 8 years of clinical experience in infectious diseases and 22 years of translational research experience in disease immunopathogenesis. As a corresponding author, she has published 52 peer-reviewed articles on microbiome and disease immunopathogenesis in high-profile journals like Microbiome, Arthritis & Rheumatology, J Autoimmunity, and EbioMedicine, bringing her total number of peer-reviewed publications to 101. As a physician-scientist, she has served as Principal Investigator on five R01 grants from NIAID or NIDA, along with a VA clinical merit grant, focusing on microbiomes, drug abuse, autoimmunity, and HIV immunopathogenesis. Her research primarily focuses on two major areas. The first is understanding the role of B cell perturbation and autoantibodies in disease pathogenesis, particularly in HIV and SLE. In 2017, her team first determined that autoimmunity impacts antiretroviral therapy outcomes in HIV without inducing autoimmune disease. This concept was later corroborated in studies on COVID-19. Her team is currently developing monoclonal autoantibodies and inhibitors to prevent anti-CD4 autoantibody binding, aiming to improve CD4+ T cell recovery and reduce morbidity in HIV patients. The second area of focus is the role of microbiomes in disease pathogenesis, including HIV, SLE, and drug abuse. She has identified the impact of disease-associated pathobionts on immune perturbations and disease progression, with findings validated in animal models. Her microbiome research is supported by R01DA055523.

TRAINING, PROFESSIONAL APPOINTMENTS

She currently serves on the Appointment, Promotion & Tenure (APT) committee in the Department of Microbiology and Immunology at the Medical University of South Carolina, a position she has held since 2024. She was promoted to Full Professor with tenure in the Department of Microbiology and Immunology, Division of Infectious Diseases, Department of Medicine at the same institution in 2023. She has been a Faculty Senator for the College of Medicine and a Research Health Scientist at the Ralph H. Johnson VA Medical Center since 2022. Additionally, she is a member of the Translational Science Laboratory IAC (2020-2022) and the MUSC College’s Curriculum Committee (2019-Present). She has held various positions at MUSC, including Associate Professor (2018-2022) and Assistant Professor (2012-2018) in the Department of Microbiology and Immunology. Since 2018, she has been a member of the Hollings Cancer Center at MUSC and has served on the award committee for the Advancement, Recruitment, and Retention of Women in Science. Her academic career began as an Instructor (2008-2012) and Research Associate (2002-2008) at Case Western Reserve University School of Medicine in Cleveland, OH.

AWARDS

She received her Chinese Board of Internal Medicine certification in Infectious Diseases in July 1997 and was certified as an Attending Medical Doctor in Infectious Diseases in November 1999 (No: 10203C089758). In July 1997, she also earned a Teacher Qualification from the Educational Institute, National Educational Committee in China (No: 971100071069382). Her licensure is from Beijing, China.

She has received several awards throughout her career, including the Laboratory Travel Grant from the American Association of Immunologists (AAI) in 2019, the MUSC High Impact Research Publication Award in 2019, and multiple travel grants from AAI for various international immunology congresses. She was awarded the Early Career Faculty Travel Grant by AAI and ECI in 2018 and 2017, and received the Travel Award and HIV Section Chair recognition at the 2016 International Congress of Immunology. In 2015, she was honored with the MUSC Foundation Developing Scholar Award and an Early Career Faculty Travel Grant from AAI. Her earlier achievements include multiple Young Investigator Awards from the 13th and 15th Conferences on Retroviruses and Opportunistic Infections (2006, 2008) and the Keystone Meeting on HIV Pathogenesis (2006, 2008). Additionally, she was recognized as an Outstanding Student Leader for five consecutive years during her medical school years from 1986 to 1991.

OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS

She has held several key professional roles and memberships throughout her career. Since 2024, she has been serving as a mentor for the American Society for Microbiology (ASM) Future Leaders Mentorship Fellowship (FLMF) Program. She is a member of the Society on NeuroImmune Pharmacology 2024 committee and has been a Treasurer Elect for the Association of Chinese Virologists in America from 2022 to 2024. She has been a member of the American Society for Microbiology (ASM) since 2021 and the Infectious Diseases Society of America (IDSA) since 2020. She has also been serving on the Editorial Board of the Journal of Neuroimmune Pharmacology since 2019 and is a member of the Society on NeuroImmune Pharmacology. Additionally, she has been part of the Society of Chinese Bioscientists in America (SCBA) and the American College of Rheumatology since 2018. She has contributed as an award committee member for the Advancement, Recruitment, and Retention of Women in Science at the Medical University of South Carolina since 2017 and is an associate member of the Hollings Cancer Center at MUSC.

She is also an active member of the MUSC Oral Health Center, College of Dental Medicine, and the Medical University of South Carolina College of Graduate Studies. Her previous memberships include being part of the American Association of Immunologists from 2011 to 2021, the Center for AIDS Research from 2008 to 2012, and the AIDS Clinic Trial Group since 2008. Her certification in Chinese Board of Internal Medicine in Infectious Diseases dates back to 1997, along with her teacher qualification from the Educational Institute, National Educational Committee, China.

CURRENT RESEARCH PROJECTS

She is currently leading several impactful research projects. As the Principal Investigator (PI) on R01DA059854 (9/30/2024-5/31/2029), funded by NIDA with a total of $3,924,302, she is studying the impacts of drug abuse-mediated inflammatory perturbations on affinity maturation of anti-CD4 autoantibodies and poor immune reconstitution from ART in HIV. This project aims to understand the role of cocaine in autoimmunity and immune recovery in HIV patients. Her role in this project is as PI (25% effort).

She is also a multiPI on R01DA059538 (9/30/2023-7/31/2028), with a total of $1,724,585 from NIDA, investigating host gene isoforms contributing to HIV persistence in cocaine users. The study focuses on identifying gene isoforms associated with HIV infection in elite controllers and its implications for cocaine users. Her role is PI (25% effort).

In addition, she is the PI on I01CX002422 (3/1/2022-2/28/2026), funded by the VA Medical Center CSRD Merit with a total of $1,195,899. This project examines the mechanism of autoreactive B cell-mediated immunological failure in HIV-infected individuals on antiretroviral therapy despite virologic suppression. She is focused on understanding the molecular mechanisms of anti-CD4 IgG-producing B cells and the pathologic effects of anti-CD4 autoantibodies. Her role is PI with 62.5% effort.

Additionally, she is involved as multiPI on R01DA055523 (9/30/2022-7/31/2027), with a total funding of $1,731,992, where she is working alongside Fitting to investigate the effects of microbiome-related mechanisms on H

 Publication